No Data
Cotuo Biotech: Report for the third quarter of 2024
Express News | Beijing Scitop Bio-Tech: Shareholders collectively plan to reduce their shareholding by no more than 4% of the company's shares
beijing scitop bio-tech (300858.SZ): The food sector's research and development production base project is expected to reach the scheduled usable state on June 30, 2025.
Gelonghui, September 20th | Beijing Scitop Bio-Tech (300858.SZ) stated on the investor interaction platform that the food sector research and production base project is expected to reach the planned usable status by June 30, 2025, currently undergoing civil construction work and has signed relevant contracts with major equipment suppliers.
Beijing Scitop Bio-tech (300858.SZ): Postbiotic products can be applied in snack food, daily chemical products, beauty and female personal care products.
Ketuo Biology (300858.SZ) stated on the investor interaction platform that postbiotics refers to genetically defined inactivated microorganisms and/or bacterial components that are beneficial to the host's health, including or excluding their metabolic products; excluding chemically synthesized components and viruses/bacteriophage and their products. Currently, the company's postbiotic products can be applied in snack food, daily chemicals, cosmetics, and female personal care products.
Beijing Scitop Bio-Tech (300858): Probiotics growing rapidly, releasing new production capacity for animal and plant microecological agents.
Event: The company has released its 2024 interim report. In the first half of the year, the company achieved revenue of 0.138 billion yuan, a year-on-year decrease of 1.3%; achieved net income attributable to shareholders of 0.044 billion yuan, a year-on-year increase of 7.9%; achieved non-recurring net income attributable to shareholders of 0.
Beijing Scitop Bio-Tech (300858): The effect of strategic transformation is evident, with high non-GAAP profit growth.
In the overview of the event, Company 24H1 achieved revenue of 0.138 billion yuan, -1.34% year-on-year, achieving a net income attributable to the parent company of 43.51 million yuan, +7.89% year-on-year, achieving a non-net income attributable to the parent company of 37.64 million yuan, +17.3% year-on-year.
No Data
No Data